Literature DB >> 9313752

Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.

S J Koopmans1, L Ohman, J R Haywood, L J Mandarino, R A DeFronzo.   

Abstract

Epidemiological studies have suggested an association among chronic hyperinsulinemia, insulin resistance, and hypertension. However, the causality of this relationship remains uncertain. In this study, chronically catheterized conscious rats were made hyperinsulinemic for 7 days (approximately 90 mU/l, i.e., threefold over basal), while strict euglycemia was maintained (approximately 130 mg/dl, coefficient of variation < 10%) by using a modification of the insulin/glucose clamp technique. Control rats received vehicle infusion. Baseline mean arterial pressure and heart rate were 125 +/- 5 mmHg and 427 +/- 12 beats/min and remained unchanged during the 7-day infusion of insulin (127 +/- 7 mmHg; 401 +/- 12 beats/min) or vehicle (133 +/- 4 mmHg; 411 +/- 10 beats/min). Baseline plasma epinephrine (88 +/- 15 pg/ml), norepinephrine (205 +/- 31 pg/ml), and sodium balance (0.34 +/- 0.09 mmol) remained constant during the 7-day insulin or vehicle infusion. After 7 days of insulin or vehicle infusion, in vivo insulin action was determined in all rats using a 2-h hyperinsulinemic (1 mU/min) euglycemic clamp with [3-3H]glucose infusion to quantitate whole-body glucose uptake, glycolysis, glucose storage (total glucose uptake minus glycolysis), and hepatic glucose production. Compared with vehicle-treated rats, 7 days of sustained hyperinsulinemia resulted in a reduction (P < 0.01) in insulin-mediated glucose uptake, glucose storage, and glycolysis by 39, 62, and 26%, respectively. Hepatic glucose production was normally suppressed after 7 days of hyperinsulinemia. Neither insulin-stimulated glucose uptake nor glucose storage correlated with blood pressure or heart rate. In conclusion, 7 days of euglycemic hyperinsulinemia induces severe insulin resistance with respect to whole-body glucose metabolism but does not increase blood pressure, catecholamine levels, or sodium retention. This indicates that hyperinsulinemia-induced insulin resistance is not associated with the development of hypertension in rats who do not have a genetic predisposition for hypertension. Because hyperinsulinemia was initiated in normal rats under euglycemic conditions, additional (inherited or acquired) factors may be necessary to observe an effect of hyperinsulinemia and/or insulin resistance to increase blood pressure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313752     DOI: 10.2337/diacare.46.10.1572

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons.

Authors:  Cynthia L Blanco; Lisa L McGill-Vargas; Amalia Gastaldelli; Steven R Seidner; Donald C McCurnin; Michelle M Leland; Diana G Anzueto; Marney C Johnson; Hanyu Liang; Ralph A DeFronzo; Nicolas Musi
Journal:  Endocrinology       Date:  2015-01-05       Impact factor: 4.736

3.  Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport.

Authors:  Alicia M McCarthy; Kristen O Spisak; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-14       Impact factor: 4.249

4.  Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1.

Authors:  Sanhua Leng; Wenshuo Zhang; Yanbin Zheng; Ziva Liberman; Christopher J Rhodes; Hagit Eldar-Finkelman; Xiao Jian Sun
Journal:  J Endocrinol       Date:  2010-05-13       Impact factor: 4.286

5.  Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway.

Authors:  M Ueno; J B C Carvalheira; R C Tambascia; R M N Bezerra; M E Amaral; E M Carneiro; F Folli; K G Franchini; M J A Saad
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

Review 6.  Sodium-retaining effect of insulin in diabetes.

Authors:  Michael W Brands; M Marlina Manhiani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-03       Impact factor: 3.619

7.  Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.

Authors:  Troy L Merry; Melanie Tran; Garron T Dodd; Salvatore P Mangiafico; Florian Wiede; Supreet Kaur; Catriona L McLean; Sofianos Andrikopoulos; Tony Tiganis
Journal:  Diabetologia       Date:  2016-09-15       Impact factor: 10.122

8.  Nitric Oxide Exerts Basal and Insulin-Dependent Anorexigenic Actions in POMC Hypothalamic Neurons.

Authors:  Leigh Wellhauser; Jennifer A Chalmers; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2016-03-01

9.  Chronic renal artery insulin infusion increases mean arterial pressure in male Sprague-Dawley rats.

Authors:  Debra L Irsik; Jian-Kang Chen; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-27

Review 10.  Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.

Authors:  Ralph A DeFronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.